Which is the preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment? Full Text
Cardiovascular Diabetology,

Mallat SG – Clinical studies suggest that in CV high–risk patients and those with evidence of renal disease, the use of an ARB/CCB combination may be preferred to ARB/HCTZ combinations due to superior renoprotective and CV benefits and reduced metabolic side effects in patients with concomitant metabolic disorders. However, selection of the most appropriate antihypertensive combination should be dependent on careful review of the individual patient and appropriate consideration of drug pharmacology.

  • Hypertension is a major associated risk for organ damage and mortality, which is further heightened in patients with prior cardiovascular (CV) events, comorbid diabetes mellitus, microalbuminuria and renal impairment.
  • Given that most patients with hypertension require at least two antihypertensives to achieve blood pressure (BP) goals, identifying the most appropriate combination regimen based on individual risk factors and comorbidities is important for risk management.
  • Single–pill combinations (SPCs) containing two or more antihypertensive agents with complementary mechanisms of action offer potential advantages over free–drug combinations, including simplification of treatment regimens, convenience and reduced costs.
  • The improved adherence and convenience resulting from SPC use is recognised in updated hypertension guidelines.
  • Despite a wide choice of SPCs for hypertension treatment, clinical evidence from direct head–to–head comparisons to guide selection for individual patients is lacking.
  • However, in patients with evidence of renal disease or at greater risk of developing renal disease, such as those with diabetes mellitus, microalbuminuria and high–normal BP or overt hypertension, guidelines recommend renin–angiotensin system (RAS) blocker–based combination therapy due to superior renoprotective effects compared with other antihypertensive classes.
  • Furthermore, RAS inhibitors attenuate the oedema and renal hyperfiltration associated with calcium channel blocker (CCB) monotherapy, making them a good choice for combination therapy.
  • The occurrence of angiotensin–converting enzyme (ACE) inhibitor–induced cough supports the use of angiotensin II receptor blockers (ARBs) for RAS blockade rather than ACE inhibitors.
  • In this regard, ARB–based SPCs are available in combination with the diuretic, hydrochlorothiazide (HCTZ) or the calcium CCB, amlodipine.
  • Telmisartan, a long–acting ARB with preferential pharmacodynamic profile compared with several other ARBs, and the only ARB with an indication for the prevention of CV disease progression, is available in two SPC formulations, telmisartan/HCTZ and telmisartan/amlodipine.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Ophthalmology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Ophthalmology Articles

1 Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8. Early Treatment Diabetic Retinopathy Study Research Group Ophthalmology, August 4, 2014    Clinical Article

2 Acanthamoeba sclerokeratitis: epidemiology, clinical features, and treatment outcomes Ophthalmology, August 8, 2014    Evidence Based Medicine    Clinical Article

3 Intracameral cefuroxime and moxifloxacin used as endophthalmitis prophylaxis after cataract surgery: Systematic review of effectiveness and cost-effectiveness Full Text Clinical Ophthalmology, August 27, 2014    Free full text    Review Article

4 A binocular iPad treatment for amblyopic children Eye, August 13, 2014    Clinical Article

5 The Handy Eye Check: A mobile medical application to test visual acuity in children Journal of AAPOS, August 1, 2014    Clinical Article

6 Cambridge community Optometry Glaucoma Scheme (COGS) Clinical and Experimental Ophthalmology, August 5, 2014    Clinical Article

7 Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial JAMA Ophthalmology, July 18, 2014    Clinical Article

8 Omega-3 Supplementation combined with anti-VEGF Lowers Vitreal Levels of VEGF in Wet Age-Related Macular Degeneration American Journal of Ophthalmology, August 11, 2014    Clinical Article

9 Lens-based glaucoma surgery: Using cataract surgery to reduce intraocular pressure Journal of Cataract & Refractive Surgery, August 15, 2014    Clinical Article

10 Twice-daily brinzolamide/brimonidine fixed combination versus brinzolamide or brimonidine in open-angle glaucoma or ocular hypertension Ophthalmology, August 6, 2014    Clinical Article

11 Monthly versus as-needed ranibizumab injections in patients with retinal vein occlusion Ophthalmology, August 7, 2014    Clinical Article

12 The effect of low-concentration atropine combined with auricular acupoint stimulation in myopia control Complementary Therapies in Medicine, August 20, 2014    Clinical Article

13 Complications in the first 5 years following cataract surgery in infants with and without intraocular lens implantation in the Infant Aphakia Treatment Study American Journal of Ophthalmology, August 12, 2014    Clinical Article

14 Systematic review and meta-analysis on the efficacy of selective laser trabeculoplasty in open-angle glaucoma Survey of Ophthalmology, August 25, 2014    Evidence Based Medicine    Review Article

15 Can the Alexander Technique improve balance and mobility in older adults with visual impairments? A randomized controlled trial Clinical Rehabilitation, July 24, 2014    Clinical Article

16 28-day intraocular pressure reduction with a single dose of brimonidine tartrate-loaded microspheres Experimental Eye Research, July 15, 2014    Clinical Article

17 Effect of sulodexide in patients with non-proliferative diabetic retinopathy: Diabetic retinopathy sulodexide study (DRESS) Graefe's Archive for Clinical and Experimental Ophthalmology, August 25, 2014    Clinical Article

18 Safety and efficacy of fixed-combination travoprost/timolol in patients with open-angle glaucoma or ocular hypertension not controlled with timolol monotherapy Full Text Clinical Ophthalmology, August 22, 2014    Free full text    Clinical Article

19 Additive effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops Cornea, August 26, 2014    Clinical Article

20 Fingernail-induced corneal abrasions: case series from an Ophthalmology Emergency Department Cornea, June 26, 2014    Clinical Article

Indexed Journals in Ophthalmology: American Journal of Ophthalmology, Retina, Eye, Corneamore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close